Enovis (ENOV) Cost of Revenue (2010 - 2026)
Enovis' (ENOV) quarterly Cost of Revenue came in at $223.5 million in Q3 2026, down 2.75% year-over-year from $229.8 million in Q3 2025, and little changed quarter-over-quarter from $223.7 million in Q2 2026.
Analysis
Enovis (ENOV) Cost of Revenue (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cost of Revenue for 17 consecutive years, with $223.5 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Cost of Revenue fell 2.75% year-over-year to $223.5 million in Q3 2026; TTM through Jul 2026 was $893.5 million, a 3.78% decrease from a year earlier, with the FY2025 full-year figure at $902.8 million, down 2.6% from the prior year.
- Cost of Revenue was $223.5 million for Q3 2026 at Enovis, roughly flat from $223.7 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $253.5 million in Q4 2024 and troughed at $168.0 million in Q3 2022.
- A 5-year average of $204.8 million and a median of $218.6 million in 2024 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue slumped 66.63% in 2022 and jumped 32.96% in 2024, its largest moves.
- Over 5 years, Cost of Revenue stood at $177.0 million in 2022, then increased by 7.73% to $190.6 million in 2023, then jumped by 32.96% to $253.5 million in 2024, then decreased by 10.7% to $226.3 million in 2025, then declined by 1.24% to $223.5 million in 2026.
- The last three Cost of Revenue figures came in at $223.5 million (Q3 2026), $223.7 million (Q2 2026), and $226.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 223.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 223.53 Mn |
| Apr 3, 2026 | 223.67 Mn |
| Dec 31, 2025 | 226.34 Mn |
| Oct 3, 2025 | 220.00 Mn |
| Jul 4, 2025 | 229.85 Mn |
| Apr 4, 2025 | 226.61 Mn |
| Dec 31, 2024 | 253.46 Mn |
| Sep 27, 2024 | 218.76 Mn |
| Jun 28, 2024 | 236.28 Mn |
| Mar 29, 2024 | 218.37 Mn |
| Dec 31, 2023 | 190.63 Mn |
| Sep 29, 2023 | 174.56 Mn |
| Jun 30, 2023 | 180.14 Mn |
| Mar 31, 2023 | 171.09 Mn |
| Dec 31, 2022 | 176.96 Mn |
| Sep 30, 2022 | 167.99 Mn |
| Jul 1, 2022 | 179.21 Mn |
| Apr 1, 2022 | 169.56 Mn |
| Dec 31, 2021 | 191.13 Mn |
| Oct 1, 2021 | 162.05 Mn |